Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inolife Sciences is a private Canadian life science and medical device company focused on needle-free drug delivery systems. The company commercializes patented, FDA-cleared injection devices and is also developing next-generation liquid jet and ballistics-based epidermal injection technologies for pharmaceuticals, biologics, biosimilars, anesthetics, and vaccines. Its platform is positioned as an alternative to conventional hypodermic needles to improve ease of administration, patient experience, and safety for healthcare workers. Publicly available information suggests the company has emphasized device commercialization and platform applications across multiple injectable markets rather than a traditional therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inolife Sciences.